HOGAN LOVELLS US LLP

Lobbying for LEGEND BIOTECH CORPORATION · Biotechnology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $110,000.00 income · posted Oct 16, 2025

Lobbying activity 1

Health Issues

Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.